# Influence of Central Nervous Insulin Sensitivity on Insulin Secretion

> **NCT02870361** · NA · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 15 (actual)

## Conditions studied

- Insulin Secretion

## Interventions

- **DRUG:** intranasal insulin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02870361
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2018-02
- **Final completion:** 2018-04
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02870361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02870361, "Influence of Central Nervous Insulin Sensitivity on Insulin Secretion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02870361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*